Scholarlink

Introduction <p>Dorsal pancreatic agenesis (DPA) is a rare congenital anomaly characterised by the partial or complete absence of the pancreatic body and tail, with &lt; 100 cases documented globally. Patients with incidentally detected DPA face significant long-term health risks, including diabetes mellitus (10–83%), exocrine pancreatic insufficiency (~ 30%), and pancreatitis (~ 40%). Furthermore, 15–20% of these patients may develop pancreatic ductal adenocarcinoma. This study aims to highlight the importance of screening and establishing guidelines for the long-term monitoring of individuals incidentally diagnosed with DPA.</p> Case study <p>Over five years (2018–2024), three cases of incidentally detected DPA were identified at our institution. A male in his late 60s presented with hematuria, revealing complete DPA during imaging for bladder carcinoma. Another male in his late 60s had incidental DPA diagnosed alongside a left renal mass, while a female in her late 20s was found to have DPA during evaluation for nephrolithiasis. All patients received lifestyle counselling and were advised a structured follow-up regimen involving HbA1c monitoring, stool fat analysis, abdominal ultrasound, and echocardiography every 3 to 6 months for the first 1–2 years.</p> Conclusion <p>Regular follow-up for patients with incidentally detected DPA is crucial due to the associated risk of DM and pancreatic insufficiency. Our findings support a proactive monitoring strategy, which ensures timely detection and management of potential complications, ultimately enhancing patient outcomes. Future research should aim to establish standardised guidelines for the long-term management of DPA, particularly in asymptomatic patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Incidentally detected dorsal pancreatic agenesis: hidden clinical implications

  • 期刊论文

  • 发表日期：

    2025年8月19日

查看全文
  • Gautam Shubhankar,
  • Vikas Panwar

摘要

Introduction

Dorsal pancreatic agenesis (DPA) is a rare congenital anomaly characterised by the partial or complete absence of the pancreatic body and tail, with < 100 cases documented globally. Patients with incidentally detected DPA face significant long-term health risks, including diabetes mellitus (10–83%), exocrine pancreatic insufficiency (~ 30%), and pancreatitis (~ 40%). Furthermore, 15–20% of these patients may develop pancreatic ductal adenocarcinoma. This study aims to highlight the importance of screening and establishing guidelines for the long-term monitoring of individuals incidentally diagnosed with DPA.

Case study

Over five years (2018–2024), three cases of incidentally detected DPA were identified at our institution. A male in his late 60s presented with hematuria, revealing complete DPA during imaging for bladder carcinoma. Another male in his late 60s had incidental DPA diagnosed alongside a left renal mass, while a female in her late 20s was found to have DPA during evaluation for nephrolithiasis. All patients received lifestyle counselling and were advised a structured follow-up regimen involving HbA1c monitoring, stool fat analysis, abdominal ultrasound, and echocardiography every 3 to 6 months for the first 1–2 years.

Conclusion

Regular follow-up for patients with incidentally detected DPA is crucial due to the associated risk of DM and pancreatic insufficiency. Our findings support a proactive monitoring strategy, which ensures timely detection and management of potential complications, ultimately enhancing patient outcomes. Future research should aim to establish standardised guidelines for the long-term management of DPA, particularly in asymptomatic patients.